Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 131 of 131 entries
Sorted by: Best Match Show Resources per page
Intracranial hemorrhage secondary to vitamin K deficiency in X-linked myotubular myopathy.

Neuromuscular disorders : NMD

Neese JM, Yum S, Matesanz S, Raffini LJ, Whitworth HB, Loomes KM, Mayer OH, Alcamo AM.
PMID: 34120822
Neuromuscul Disord. 2021 Jul;31(7):651-655. doi: 10.1016/j.nmd.2021.04.009. Epub 2021 May 11.

X-linked myotubular myopathy (XLMTM) is a rare congenital myopathy characterized by profound hypotonia and poor respiratory effort at birth. The condition is associated with multiple morbidities including chronic respiratory insufficiency, feeding tube dependence, and rarely, vitamin K deficiency leading...

Cite
Neese JM, Yum S, Matesanz S, et al. Intracranial hemorrhage secondary to vitamin K deficiency in X-linked myotubular myopathy. Neuromuscul Disord. 2021;31(7):651-655doi: 10.1016/j.nmd.2021.04.009.
Neese, J. M., Yum, S., Matesanz, S., Raffini, L. J., Whitworth, H. B., Loomes, K. M., Mayer, O. H., & Alcamo, A. M. (2021). Intracranial hemorrhage secondary to vitamin K deficiency in X-linked myotubular myopathy. Neuromuscular disorders : NMD, 31(7), 651-655. https://doi.org/10.1016/j.nmd.2021.04.009
Neese, Jeremy M, et al. "Intracranial hemorrhage secondary to vitamin K deficiency in X-linked myotubular myopathy." Neuromuscular disorders : NMD vol. 31,7 (2021): 651-655. doi: https://doi.org/10.1016/j.nmd.2021.04.009
Neese JM, Yum S, Matesanz S, Raffini LJ, Whitworth HB, Loomes KM, Mayer OH, Alcamo AM. Intracranial hemorrhage secondary to vitamin K deficiency in X-linked myotubular myopathy. Neuromuscul Disord. 2021 Jul;31(7):651-655. doi: 10.1016/j.nmd.2021.04.009. Epub 2021 May 11. PMID: 34120822.
Copy Download .nbib Format: NLM
Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Penetra SLS, da Silva MFB, Resende P, Pina-Costa A, Santos HFP, Guaraldo L, Calvet GA, Ogrzewalska M, Arantes I, Zukeram K, de Araújo MF, Lima ABM, Lopes RS, Lira-Silva LR, Moraes IV, Wakimoto MD, Fuller TL, Gabaglia CR, Espíndola OM, Bonaldo MC, Daniel-Ribeiro CT, Whitworth J, Smith C, Nielsen-Saines K, Pauvolid-Correa A, Siqueira MM, Brasil P.
PMID: 34757006
Int J Infect Dis. 2021 Oct 29;114:58-61. doi: 10.1016/j.ijid.2021.10.048. Epub 2021 Oct 29.

We describe a case of prolonged COVID-19 caused by the SARS-CoV-2 Gamma variant in a fully vaccinated healthcare worker, 387 days after an infection caused by lineage B.1.1.33. Infections were confirmed by whole-genome sequencing and corroborated by the detection...

Cite
Penetra SLS, da Silva MFB, Resende P, et al. Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil. Int J Infect Dis. 2021;114:58-61doi: 10.1016/j.ijid.2021.10.048.
Penetra, S. L. S., da Silva, M. F. B., Resende, P., Pina-Costa, A., Santos, H. F. P., Guaraldo, L., Calvet, G. A., Ogrzewalska, M., Arantes, I., Zukeram, K., de Araújo, M. F., Lima, A. B. M., Lopes, R. S., Lira-Silva, L. R., Moraes, I. V., Wakimoto, M. D., Fuller, T. L., Gabaglia, C. R., Espíndola, O. M., Bonaldo, M. C., Daniel-Ribeiro, C. T., Whitworth, J., Smith, C., Nielsen-Saines, K., Pauvolid-Correa, A., Siqueira, M. M., & Brasil, P. (2021). Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 11458-61. https://doi.org/10.1016/j.ijid.2021.10.048
Penetra, Stephanie L S, et al. "Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 114 (2021): 58-61. doi: https://doi.org/10.1016/j.ijid.2021.10.048
Penetra SLS, da Silva MFB, Resende P, Pina-Costa A, Santos HFP, Guaraldo L, Calvet GA, Ogrzewalska M, Arantes I, Zukeram K, de Araújo MF, Lima ABM, Lopes RS, Lira-Silva LR, Moraes IV, Wakimoto MD, Fuller TL, Gabaglia CR, Espíndola OM, Bonaldo MC, Daniel-Ribeiro CT, Whitworth J, Smith C, Nielsen-Saines K, Pauvolid-Correa A, Siqueira MM, Brasil P. Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil. Int J Infect Dis. 2021 Oct 29;114:58-61. doi: 10.1016/j.ijid.2021.10.048. Epub 2021 Oct 29. PMID: 34757006; PMCID: PMC8553653.
Copy Download .nbib Format: NLM
High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancer.

Journal of surgical oncology

Crozier JA, Barone J, Whitworth P, Cheong A, Maganini R, Tamayo JP, Dauer P, Wang S, Audeh W, Glas AM.
PMID: 34964996
J Surg Oncol. 2021 Dec 29; doi: 10.1002/jso.26780. Epub 2021 Dec 29.

BACKGROUND AND OBJECTIVES: With increased neoadjuvant therapy recommendations for early-stage breast cancer patients due to the COVID-19 pandemic, it is imperative that molecular diagnostic assays provide reliable results from preoperative core needle biopsies (CNB). The study objective was to...

Cite
Crozier JA, Barone J, Whitworth P, et al. High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancer. J Surg Oncol. 2021;doi: 10.1002/jso.26780.
Crozier, J. A., Barone, J., Whitworth, P., Cheong, A., Maganini, R., Tamayo, J. P., Dauer, P., Wang, S., Audeh, W., & Glas, A. M. (2021). High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancer. Journal of surgical oncology, . https://doi.org/10.1002/jso.26780
Crozier, Jennifer A, et al. "High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancer." Journal of surgical oncology vol. (2021). doi: https://doi.org/10.1002/jso.26780
Crozier JA, Barone J, Whitworth P, Cheong A, Maganini R, Tamayo JP, Dauer P, Wang S, Audeh W, Glas AM. High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancer. J Surg Oncol. 2021 Dec 29; doi: 10.1002/jso.26780. Epub 2021 Dec 29. PMID: 34964996.
Copy Download .nbib Format: NLM
Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Penetra SLS, da Silva MFB, Resende P, Pina-Costa A, Santos HFP, Guaraldo L, Calvet GA, Ogrzewalska M, Arantes I, Zukeram K, de Araújo MF, Lima ABM, Lopes RS, Lira-Silva LR, Moraes IV, Wakimoto MD, Fuller TL, Gabaglia CR, Espíndola OM, Bonaldo MC, Daniel-Ribeiro CT, Whitworth J, Smith C, Nielsen-Saines K, Pauvolid-Correa A, Siqueira MM, Brasil P.
PMID: 34757006
Int J Infect Dis. 2022 Jan;114:58-61. doi: 10.1016/j.ijid.2021.10.048. Epub 2021 Oct 29.

We describe a case of prolonged COVID-19 caused by the SARS-CoV-2 Gamma variant in a fully vaccinated healthcare worker, 387 days after an infection caused by lineage B.1.1.33. Infections were confirmed by whole-genome sequencing and corroborated by the detection...

Cite
Penetra SLS, da Silva MFB, Resende P, et al. Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil. Int J Infect Dis. 2021;114:58-61doi: 10.1016/j.ijid.2021.10.048.
Penetra, S. L. S., da Silva, M. F. B., Resende, P., Pina-Costa, A., Santos, H. F. P., Guaraldo, L., Calvet, G. A., Ogrzewalska, M., Arantes, I., Zukeram, K., de Araújo, M. F., Lima, A. B. M., Lopes, R. S., Lira-Silva, L. R., Moraes, I. V., Wakimoto, M. D., Fuller, T. L., Gabaglia, C. R., Espíndola, O. M., Bonaldo, M. C., Daniel-Ribeiro, C. T., Whitworth, J., Smith, C., Nielsen-Saines, K., Pauvolid-Correa, A., Siqueira, M. M., & Brasil, P. (2022). Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 11458-61. https://doi.org/10.1016/j.ijid.2021.10.048
Penetra, Stephanie L S, et al. "Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 114 (2022): 58-61. doi: https://doi.org/10.1016/j.ijid.2021.10.048
Penetra SLS, da Silva MFB, Resende P, Pina-Costa A, Santos HFP, Guaraldo L, Calvet GA, Ogrzewalska M, Arantes I, Zukeram K, de Araújo MF, Lima ABM, Lopes RS, Lira-Silva LR, Moraes IV, Wakimoto MD, Fuller TL, Gabaglia CR, Espíndola OM, Bonaldo MC, Daniel-Ribeiro CT, Whitworth J, Smith C, Nielsen-Saines K, Pauvolid-Correa A, Siqueira MM, Brasil P. Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil. Int J Infect Dis. 2022 Jan;114:58-61. doi: 10.1016/j.ijid.2021.10.048. Epub 2021 Oct 29. PMID: 34757006; PMCID: PMC8553653.
Copy Download .nbib Format: NLM
Responding to Natural and Industrial Disasters: Partnerships and Lessons Learned.

Disaster medicine and public health preparedness

Symanski E, An Han H, Han I, McDaniel M, Whitworth KW, McCurdy S, Perkison WB, Rammah A, Lewis PGT, Delclos GL, Craft E, Bondy M, Walker CL, Hopkins L, Cedeño Laurent JG, James D.
PMID: 33722331
Disaster Med Public Health Prep. 2021 Mar 16;1-4. doi: 10.1017/dmp.2020.467. Epub 2021 Mar 16.

OBJECTIVES: The aim of this study was to provide insights learned from disaster research response (DR2) efforts following Hurricane Harvey in 2017 to launch DR2 activities following the Intercontinental Terminals Company (ITC) fire in Deer Park, Texas, in 2019.METHODS:...

Cite
Symanski E, An Han H, Han I, et al. Responding to Natural and Industrial Disasters: Partnerships and Lessons Learned. Disaster Med Public Health Prep. 2021;1-4doi: 10.1017/dmp.2020.467.
Symanski, E., An Han, H., Han, I., McDaniel, M., Whitworth, K. W., McCurdy, S., Perkison, W. B., Rammah, A., Lewis, P. G. T., Delclos, G. L., Craft, E., Bondy, M., Walker, C. L., Hopkins, L., Cedeño Laurent, J. G., & James, D. (2021). Responding to Natural and Industrial Disasters: Partnerships and Lessons Learned. Disaster medicine and public health preparedness, 1-4. https://doi.org/10.1017/dmp.2020.467
Symanski, Elaine, et al. "Responding to Natural and Industrial Disasters: Partnerships and Lessons Learned." Disaster medicine and public health preparedness vol. (2021): 1-4. doi: https://doi.org/10.1017/dmp.2020.467
Symanski E, An Han H, Han I, McDaniel M, Whitworth KW, McCurdy S, Perkison WB, Rammah A, Lewis PGT, Delclos GL, Craft E, Bondy M, Walker CL, Hopkins L, Cedeño Laurent JG, James D. Responding to Natural and Industrial Disasters: Partnerships and Lessons Learned. Disaster Med Public Health Prep. 2021 Mar 16;1-4. doi: 10.1017/dmp.2020.467. Epub 2021 Mar 16. PMID: 33722331; PMCID: PMC8443687.
Copy Download .nbib Format: NLM
Correction to: The Clinical Utility of DCISionRT.

Annals of surgical oncology

Shah C, Bremer T, Cox C, Whitworth P, Patel R, Patel A, Brown E, Gold L, Rock D, Riley L, Kesslering C, Brown S, Gabordi R, Pellicane J, Rabinovich R, Khan S, Templeton S, Majithia L, Willey SC, Wärnberg F, Gerber NK, Shivers S, Vicini FA.
PMID: 33997922
Ann Surg Oncol. 2021 Dec;28:878. doi: 10.1245/s10434-021-10138-3.

No abstract available.

Cite
Shah C, Bremer T, Cox C, et al. Correction to: The Clinical Utility of DCISionRT. Ann Surg Oncol. 2021;28:878doi: 10.1245/s10434-021-10138-3.
Shah, C., Bremer, T., Cox, C., Whitworth, P., Patel, R., Patel, A., Brown, E., Gold, L., Rock, D., Riley, L., Kesslering, C., Brown, S., Gabordi, R., Pellicane, J., Rabinovich, R., Khan, S., Templeton, S., Majithia, L., Willey, S. C., Wärnberg, F., Gerber, N. K., Shivers, S., & Vicini, F. A. (2021). Correction to: The Clinical Utility of DCISionRT. Annals of surgical oncology, 28878. https://doi.org/10.1245/s10434-021-10138-3
Shah, Chirag, et al. "Correction to: The Clinical Utility of DCISionRT." Annals of surgical oncology vol. 28 (2021): 878. doi: https://doi.org/10.1245/s10434-021-10138-3
Shah C, Bremer T, Cox C, Whitworth P, Patel R, Patel A, Brown E, Gold L, Rock D, Riley L, Kesslering C, Brown S, Gabordi R, Pellicane J, Rabinovich R, Khan S, Templeton S, Majithia L, Willey SC, Wärnberg F, Gerber NK, Shivers S, Vicini FA. Correction to: The Clinical Utility of DCISionRT. Ann Surg Oncol. 2021 Dec;28:878. doi: 10.1245/s10434-021-10138-3. PMID: 33997922.
Copy Download .nbib Format: NLM
Comment on "mt-Keima detects PINK1-PRKN mitophagy in vivo with greater sensitivity than .

Autophagy

Ganley IG, Whitworth AJ, McWilliams TG.
PMID: 33818280
Autophagy. 2021 Dec;17(12):4477-4479. doi: 10.1080/15548627.2021.1907269. Epub 2021 Apr 05.

No abstract available.

Cite
Ganley IG, Whitworth AJ, McWilliams TG. Comment on "mt-Keima detects PINK1-PRKN mitophagy in vivo with greater sensitivity than . Autophagy. 2021;17(12):4477-4479doi: 10.1080/15548627.2021.1907269.
Ganley, I. G., Whitworth, A. J., & McWilliams, T. G. (2021). Comment on "mt-Keima detects PINK1-PRKN mitophagy in vivo with greater sensitivity than . Autophagy, 17(12), 4477-4479. https://doi.org/10.1080/15548627.2021.1907269
Ganley, Ian G, et al. "Comment on "mt-Keima detects PINK1-PRKN mitophagy in vivo with greater sensitivity than ." Autophagy vol. 17,12 (2021): 4477-4479. doi: https://doi.org/10.1080/15548627.2021.1907269
Ganley IG, Whitworth AJ, McWilliams TG. Comment on "mt-Keima detects PINK1-PRKN mitophagy in vivo with greater sensitivity than . Autophagy. 2021 Dec;17(12):4477-4479. doi: 10.1080/15548627.2021.1907269. Epub 2021 Apr 05. PMID: 33818280; PMCID: PMC8726702.
Copy Download .nbib Format: NLM
Prevention of Recurrent Thrombotic Events in Children with Central Venous Catheter-Associated Venous Thrombosis.

Blood

Clark HH, Ballester L, Whitworth HB, Raffini L, Witmer C.
PMID: 34727184
Blood. 2021 Nov 02; doi: 10.1182/blood.2021013453. Epub 2021 Nov 02.

Central venous catheters (CVC) are the most significant risk factor for pediatric venous thromboembolism (VTE). After an index CVC-associated VTE (CVC-VTE), the role of secondary prophylaxis for subsequent CVC placement is uncertain. Aims of this single center retrospective study...

Cite
Clark HH, Ballester L, Whitworth HB, et al. Prevention of Recurrent Thrombotic Events in Children with Central Venous Catheter-Associated Venous Thrombosis. Blood. 2021;doi: 10.1182/blood.2021013453.
Clark, H. H., Ballester, L., Whitworth, H. B., Raffini, L., & Witmer, C. (2021). Prevention of Recurrent Thrombotic Events in Children with Central Venous Catheter-Associated Venous Thrombosis. Blood, . https://doi.org/10.1182/blood.2021013453
Clark, Helen Havens, et al. "Prevention of Recurrent Thrombotic Events in Children with Central Venous Catheter-Associated Venous Thrombosis." Blood vol. (2021). doi: https://doi.org/10.1182/blood.2021013453
Clark HH, Ballester L, Whitworth HB, Raffini L, Witmer C. Prevention of Recurrent Thrombotic Events in Children with Central Venous Catheter-Associated Venous Thrombosis. Blood. 2021 Nov 02; doi: 10.1182/blood.2021013453. Epub 2021 Nov 02. PMID: 34727184.
Copy Download .nbib Format: NLM
Personalized Radiation Attenuating Materials for Gastrointestinal Mucosal Protection.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Byrne JD, Young CC, Chu JN, Pursley J, Chen MX, Wentworth AJ, Feng A, Kirtane AR, Remillard KA, Hancox CI, Bhagwat MS, Machado N, Hua T, Tamang SM, Collins JE, Ishida K, Hayward A, Becker SL, Edgington SK, Schoenfeld JD, Jeck WR, Hur C, Traverso G.
PMID: 34194950
Adv Sci (Weinh). 2021 Apr 27;8(12):2100510. doi: 10.1002/advs.202100510. eCollection 2021 Jun.

Cancer patients undergoing therapeutic radiation routinely develop injury of the adjacent gastrointestinal (GI) tract mucosa due to treatment. To reduce radiation dose to critical GI structures including the rectum and oral mucosa, 3D-printed GI radioprotective devices composed of high-Z...

Cite
Byrne JD, Young CC, Chu JN, et al. Personalized Radiation Attenuating Materials for Gastrointestinal Mucosal Protection. Adv Sci (Weinh). 2021;8(12):2100510doi: 10.1002/advs.202100510.
Byrne, J. D., Young, C. C., Chu, J. N., Pursley, J., Chen, M. X., Wentworth, A. J., Feng, A., Kirtane, A. R., Remillard, K. A., Hancox, C. I., Bhagwat, M. S., Machado, N., Hua, T., Tamang, S. M., Collins, J. E., Ishida, K., Hayward, A., Becker, S. L., Edgington, S. K., Schoenfeld, J. D., Jeck, W. R., Hur, C., & Traverso, G. (2021). Personalized Radiation Attenuating Materials for Gastrointestinal Mucosal Protection. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 8(12), 2100510. https://doi.org/10.1002/advs.202100510
Byrne, James D, et al. "Personalized Radiation Attenuating Materials for Gastrointestinal Mucosal Protection." Advanced science (Weinheim, Baden-Wurttemberg, Germany) vol. 8,12 (2021): 2100510. doi: https://doi.org/10.1002/advs.202100510
Byrne JD, Young CC, Chu JN, Pursley J, Chen MX, Wentworth AJ, Feng A, Kirtane AR, Remillard KA, Hancox CI, Bhagwat MS, Machado N, Hua T, Tamang SM, Collins JE, Ishida K, Hayward A, Becker SL, Edgington SK, Schoenfeld JD, Jeck WR, Hur C, Traverso G. Personalized Radiation Attenuating Materials for Gastrointestinal Mucosal Protection. Adv Sci (Weinh). 2021 Apr 27;8(12):2100510. doi: 10.1002/advs.202100510. eCollection 2021 Jun. PMID: 34194950; PMCID: PMC8224439.
Copy Download .nbib Format: NLM
Does the number of doses matter? A qualitative study of HPV vaccination acceptability nested in a dose reduction trial in Tanzania.

Tumour virus research

Mitchell KR, Erio T, Whitworth HS, Marwerwe G, Changalucha J, Baisley K, Lacey CJ, Hayes R, de SanJosé S, Watson-Jones D.
PMID: 34051389
Tumour Virus Res. 2021 Dec;12:200217. doi: 10.1016/j.tvr.2021.200217. Epub 2021 May 26.

BACKGROUND: The multi-dose regimen is a known barrier to successful human papillomavirus (HPV) vaccination. Emerging evidence suggests that one vaccine dose could protect against HPV. While there are clear advantages to a single dose schedule, beliefs about vaccine dosage...

Cite
Mitchell KR, Erio T, Whitworth HS, et al. Does the number of doses matter? A qualitative study of HPV vaccination acceptability nested in a dose reduction trial in Tanzania. Tumour Virus Res. 2021;12:200217doi: 10.1016/j.tvr.2021.200217.
Mitchell, K. R., Erio, T., Whitworth, H. S., Marwerwe, G., Changalucha, J., Baisley, K., Lacey, C. J., Hayes, R., de SanJosé, S., & Watson-Jones, D. (2021). Does the number of doses matter? A qualitative study of HPV vaccination acceptability nested in a dose reduction trial in Tanzania. Tumour virus research, 12200217. https://doi.org/10.1016/j.tvr.2021.200217
Mitchell, K R, et al. "Does the number of doses matter? A qualitative study of HPV vaccination acceptability nested in a dose reduction trial in Tanzania." Tumour virus research vol. 12 (2021): 200217. doi: https://doi.org/10.1016/j.tvr.2021.200217
Mitchell KR, Erio T, Whitworth HS, Marwerwe G, Changalucha J, Baisley K, Lacey CJ, Hayes R, de SanJosé S, Watson-Jones D. Does the number of doses matter? A qualitative study of HPV vaccination acceptability nested in a dose reduction trial in Tanzania. Tumour Virus Res. 2021 Dec;12:200217. doi: 10.1016/j.tvr.2021.200217. Epub 2021 May 26. PMID: 34051389; PMCID: PMC8233223.
Copy Download .nbib Format: NLM
Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS).

Cancers

Wärnberg F, Karlsson P, Holmberg E, Sandelin K, Whitworth PW, Savala J, Barry T, Leesman G, Linke SP, Shivers SC, Vicini F, Shah C, Weinmann S, Mann GB, Bremer T.
PMID: 34885211
Cancers (Basel). 2021 Dec 03;13(23). doi: 10.3390/cancers13236103.

Prediction of radiotherapy (RT) benefit after breast-conserving surgery (BCS) for DCIS is crucial. The aim was to validate a biosignature, DCISionRT

Cite
Wärnberg F, Karlsson P, Holmberg E, et al. Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS). Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13236103.
Wärnberg, F., Karlsson, P., Holmberg, E., Sandelin, K., Whitworth, P. W., Savala, J., Barry, T., Leesman, G., Linke, S. P., Shivers, S. C., Vicini, F., Shah, C., Weinmann, S., Mann, G. B., & Bremer, T. (2021). Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS). Cancers, 13(23), . https://doi.org/10.3390/cancers13236103
Wärnberg, Fredrik, et al. "Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13236103
Wärnberg F, Karlsson P, Holmberg E, Sandelin K, Whitworth PW, Savala J, Barry T, Leesman G, Linke SP, Shivers SC, Vicini F, Shah C, Weinmann S, Mann GB, Bremer T. Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS). Cancers (Basel). 2021 Dec 03;13(23). doi: 10.3390/cancers13236103. PMID: 34885211.
Copy Download .nbib Format: NLM
Showing 121 to 131 of 131 entries